(lp0
S"MEDNAX Announces Acquisition of Ophthalmology Practice in Nevada Business Wire  - Mar 23, 2017 MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services.M&amp;A: MEDNAX Inc  Makes Fifth Physician Group Acquisition In 2017 - Stock Market Daily"
p1
aS"Analyst's Indicator Review for MEDNAX, Inc. , Northern Trust Corporation ... The USA Commerce - Mar 27, 2017 Shares of MEDNAX, Inc.  surged 2.15% to $69.27. During the trading on 03/24/2017, Company's stock ranged from $69.68 to $67.94."
p2
aS'Stock Target Review on Mednax, Inc  Shares Aiken Advocate - 14 hours ago Wall Street sell-side analysts have given shares of Mednax, Inc  a near-term target price of $68.285. This is the consensus number provided by analysts used by Zacks Research.'
p3
aS'MEDNAX Inc.: MEDNAX Announces Acquisition of Maternal-Fetal Medicine Practice ... The Wall Street Transcript - Mar 13, 2017 FORT LAUDERDALE, Fla.----Mar. 13, 2017-- MEDNAX, Inc. , today announced the acquisition of Midwest Perinatal Associates, P.A.MEDNAX  announced acquisition of Midwest Perinatal Associates - Benchmark Monitor'
p4
aS'Mednax Reaches Analyst Target Price Nasdaq - Mar 27, 2017 In recent trading, shares of Mednax, Inc.  have crossed above the average analyst 12-month target price of $68.28, changing hands for $69.27/share.'
p5
aS"Buy or Sell? Average Brokerage Ratings on Vantiv, Inc. , MEDNAX, Inc.  StockNewsJournal - Mar 23, 2017 MEDNAX, Inc. , maintained return on investment for the last twelve months at 7.21, higher than what Reuters data shows regarding industry's average."
p6
aS'Analytical Guide for AO Smith Corporation , MEDNAX, Inc.  Stakeholders The USA Commerce - Mar 22, 2017 While trading at volume above than average, MEDNAX, Inc.  previous 52-week high was $76.96 and moved up 6.36% over the same period, trading at a volume of 890.91 thousand.'
p7
aS'MEDNAX Inc  Rating Lowered to Sell at Zacks Investment Research BBNS - Mar 27, 2017 MEDNAX logo MEDNAX Inc  was downgraded by Zacks Investment Research from a hold rating to a sell rating in a report issued on Thursday.MEDNAX Inc  Rating Lowered to Neutral at Robert W. Baird - Community Financial News'
p8
aS'MEDNAX Inc  Cut to Sell at Zacks Investment Research Community Financial News - 16 hours ago MEDNAX Inc logo Zacks Investment Research downgraded shares of MEDNAX Inc  from a hold rating to a sell rating in a research note released on Thursday morning.'
p9
aS'Baird Downgrades MEDNAX Inc to Neutral Money Flow Index & Trends - 12 hours ago Brokerage firm Baird Downgrades its rating on MEDNAX Inc. The shares have been rated Neutral. Previously, the analysts had a Outperform rating on the shares.'
p10
a.